
BRAINCELLS’ SYSTEM COMBINES IN VITRO AND IN VIVO RESULTS TO PROVIDE ACTIONABLE DATA
The BrainCells platform is connected through a proprietary and comprehensive informatics capability that enables the capture, analysis and management of data generated from all assay systems in an automated, quantitative way.
The BrainCells platform takes advantage of a database built from all previously executed assays. This storehouse of data allows BrainCells to do cross-category analysis to show how the neurogenic fingerprint of a new drug candidate compares to all previously tested compounds. This facilitates the identification of drug profiles most likely to be successful.